Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

Background. Iron deficiency anemia (IDA) is a common hematological complication with potentially serious clinical consequences that may require intravenous iron therapy. Ferric carboxymaltose (FCM) is a stable, nondextran iron formulation administered intravenously in large single doses to treat IDA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Barish, Charles F., Koch, Todd, Butcher, Angelia, Morris, David, Bregman, David B.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3444829/
https://ncbi.nlm.nih.gov/pubmed/22997572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/172104
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares